"Designing Growth Strategies is in our DNA"

Biopharmaceutical CMO Downstream Processing Market Size, Share & Industry Analysis, By Technique (Purification, Concentration, and Others), By Source (Mammalian and Non-mammalian), By Product (Biologics and Biosimilars), and Regional Forecast, 2025-2032

Last Updated: December 23, 2025 | Format: PDF | Report ID: FBI114912

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities 
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
    3. Technological Advancements in Biopharmaceutical Processing
  5. Global Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1.  U.K.
      2.  Germany
      3.  France
      4.  Spain
      5.  Italy
      6.  Scandinavia
      7.  Rest of Europe
  8. Asia pacific Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1.  Japan
      2.  China
      3.  India
      4.  Australia
      5.  Southeast Asia
      6.  Rest of Asia Pacific
  9. Latin America Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1.  Brazil
      2.  Mexico
      3.  Rest of Latin America
  10. Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC 
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Samsung Biologics
      2. Lonza 
      3. Recipharm AB 
      4. WuXi Biologics 
      5. FUJIFILM (FUJIFILM Diosynth Biotechnologies) 
      6. Siegfried Holding AG
      7. Cambrex Corporation 
      8. Catalent, Inc.
      9. Thermo Fisher Scientific Inc. (Patheon)
      10. Other Prominent Players
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities 
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
    3. Technological Advancements in Biopharmaceutical Processing
  5. Global Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1.  U.K.
      2.  Germany
      3.  France
      4.  Spain
      5.  Italy
      6.  Scandinavia
      7.  Rest of Europe
  8. Asia pacific Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1.  Japan
      2.  China
      3.  India
      4.  Australia
      5.  Southeast Asia
      6.  Rest of Asia Pacific
  9. Latin America Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian 
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1.  Brazil
      2.  Mexico
      3.  Rest of Latin America
  10. Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technique
      1.  Purification
      2. Concentration
      3. Others
    2. Market Analysis, Insights and Forecast – By Source
      1. Mammalian
      2. Non-mammalian
    3. Market Analysis, Insights and Forecast – By Product
      1. Biologics
      2. Biosimilars
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC 
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Samsung Biologics
      2. Lonza 
      3. Recipharm AB 
      4. WuXi Biologics 
      5. FUJIFILM (FUJIFILM Diosynth Biotechnologies) 
      6. Siegfried Holding AG
      7. Cambrex Corporation 
      8. Catalent, Inc.
      9. Thermo Fisher Scientific Inc. (Patheon)
      10. Other Prominent Players
Read Less

Figure 1: Global Biopharmaceutical CMO Downstream Processing Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Technique, 2024 & 2032

Figure 3: Global Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Source, 2024 & 2032

Figure 4: Global Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Product, 2024 & 2032

Figure 5: Global Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Region, 2024 & 2032

Figure 6: North America Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Technique, 2024 & 2032

Figure 7: North America Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Technique, 2024

Figure 8: North America Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Source, 2024 & 2032

Figure 9: North America Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Source, 2024

Figure 10: North America Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Product, 2024 & 2032

Figure 11: North America Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Product, 2024

Figure 12: North America Biopharmaceutical CMO Downstream Processing Market Value (USD billion), By Country, 2024 & 2032

Figure 13: North America Biopharmaceutical CMO Downstream Processing Market Value Share (%), By Country, 2024

Figure 14: Europe Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Technique, 2024 & 2032

Figure 15: Europe Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Technique, 2024

Figure 16: Europe Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Source, 2024 & 2032

Figure 17: Europe Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Source, 2024

Figure 18: Europe Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Product, 2024 & 2032

Figure 19: Europe Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Product, 2024

Figure 20: Europe Biopharmaceutical CMO Downstream Processing Market Value (USD billion), By Country/Sub-region, 2024 & 2032

Figure 21: Europe Biopharmaceutical CMO Downstream Processing Market Value Share (%), By Country/Sub-region, 2024

Figure 22: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Technique, 2024 & 2032

Figure 23: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Technique, 2024

Figure 24: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Source, 2024 & 2032

Figure 25: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Source, 2024

Figure 26: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Product, 2024 & 2032

Figure 27: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Product, 2024

Figure 28: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Value (USD billion), By Country/Sub-region, 2024 & 2032

Figure 29: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Value Share (%), By Country/Sub-region, 2024

Figure 30: Latin America Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Technique, 2024 & 2032

Figure 31: Latin America Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Technique, 2024

Figure 32: Latin America Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Source, 2024 & 2032

Figure 33: Latin America Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Source, 2024

Figure 34: Latin America Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Product, 2024 & 2032

Figure 35: Latin America Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Product, 2024

Figure 36: Latin America Biopharmaceutical CMO Downstream Processing Market Value (USD billion), By Country/Sub-region, 2024 & 2032

Figure 37: Latin America Biopharmaceutical CMO Downstream Processing Market Value Share (%), By Country/Sub-region, 2024

Figure 38: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Technique, 2024 & 2032

Figure 39: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Technique, 2024

Figure 40: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Source, 2024 & 2032

Figure 41: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Source, 2024

Figure 42: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Value (USD billion), by Product, 2024 & 2032

Figure 43: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Value Share (%), by Product, 2024

Figure 44: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Value (USD billion), By Country/Sub-region, 2024 & 2032

Figure 45: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Value Share (%), By Country/Sub-region, 2024

Figure 46: Global Biopharmaceutical CMO Downstream Processing Market Share (%), 2024

Table 1: Global Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 2: Global Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Source, 2019–2032

Table 3: Global Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 4: Global Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 5: North America Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 6: North America Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Source, 2019–2032

Table 7: North America Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 8: North America Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Country, 2019-2032

Table 9: Europe Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 10: Europe Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Source, 2019–2032

Table 11: Europe Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 12: Europe Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032

Table 13: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 14: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Source, 2019–2032

Table 15: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 16: Asia Pacific Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032

Table 17: Latin America Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 18: Latin America Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Source, 2019–2032

Table 19: Latin America Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 20: Latin America Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032

Table 21: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Technique, 2019–2032

Table 22: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Source, 2019–2032

Table 23: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 24: Middle East & Africa Biopharmaceutical CMO Downstream Processing Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032

biopharmaceutical cmo downstream processing market
  • 2019-2032
  • 2025
  • 2019-2024
  • 130
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports